The Department of Health and Human Services Friday announced the new option of saliva tests at federal community-based testing sites in areas experiencing COVID-19 surge.

The tests, in which patients spit into sterile containers, are made by Fludigm Corp. with support from the National Institutes of Health. Waco, Texas, is the first surge testing site to offer the saliva tests. HHS said the test’s accuracy is comparable to other molecular-level tests of nasal swab samples, based on the manufacturer’s clinical study.

Related News Articles

Blog
The American Hospital Association and its Society for Healthcare Strategy and Market Development (SHSMD) July 15 hosted “Addressing COVID-19 Vaccine Hesitancy…
Perspective
The COVID-19 Provider Relief Fund has been a lifeline for hospitals, health systems and health care providers, allowing them to continue to put the health and…
Headline
President Biden today announced new actions to spur more vaccinations nationwide against COVID-19, due in part to the rise of the SARS-CoV-2 delta variant.…
Headline
The AHA today released new Spanish-language public service announcements and related content pieces to support vaccination efforts and complement previously…
Headline
AHA today urged the Centers for Medicare & Medicaid Services to make permanent COVID-19 waivers that removed regulatory barriers to better patient care,…
Headline
The Food and Drug Administration July 28 extended to six months the shelf life for Johnson & Johnson’s COVID-19 vaccine. The decision is based on data from…